Immunology and Microbiology
Systemic Lupus Erythematosus
100%
interferon
66%
Macrophage
58%
Systemic Scleroderma
44%
Neutrophil
31%
Fibroblast
30%
Granulomatosis with Polyangiitis
29%
Mitogen
29%
Hypoxia Inducible Factor 1
29%
Orthomyxoviridae
29%
Placenta
29%
Inflammatory Arthritis
28%
Antiphospholipid Syndrome
26%
Cytokine
23%
Upregulation
21%
Glycation
21%
Tumor Necrosis Factor Alpha
20%
Neutrophil Granulocyte
20%
Vasculotropin
18%
Oxidative Stress
18%
Autoantibodies
18%
Protein Synthesis
14%
Staphylococcus Aureus
14%
Mucosal-Associated Invariant T Cell
14%
Hepatoma Cell
14%
Granulopoiesis
14%
Neutrophil Extracellular Traps
14%
Vasculitis
14%
Granulocyte
14%
Nephritis
14%
CD177
14%
Monocyte
14%
Interleukin 21
14%
B Lymphocyte Subpopulation
14%
T Cell
14%
Transcriptomics
14%
Acute Phase Protein
14%
Chemokine
14%
Cell Line
14%
Periodontitis
14%
Rheumatic Disease
14%
Interferon
12%
Mediator
12%
Fetus Growth
11%
B Cell
11%
Lupus Erythematosus
11%
Interleukin 17
10%
Superantigen
10%
ELISA
10%
Raynaud Phenomenon
9%
Keyphrases
Macrophages
34%
Systemic Lupus Erythematosus
34%
Free Thiols
30%
Systemic Lupus Erythematosus Patient
29%
Myxovirus Resistance Protein A
29%
Placenta
29%
Healthy Controls
25%
Antiphospholipid Syndrome
24%
Lupus Nephritis
22%
Oxidative Stress
21%
Interferon-α (IFN-α)
19%
Disease Syndrome
17%
Dutch
16%
Systemic Oxidative Stress
16%
Interferon Score
14%
Clinical Transcriptomics
14%
IgG Antibody Titer
14%
Monocyte-derived Macrophages
14%
Strong Inhibition
14%
Interleukin-8
14%
Human Hepatoma Cells
14%
COVID-19
14%
Nephritis
14%
Cyclooxygenase-2
14%
Cross-sectional Clinical Study
14%
Continuous Renal Replacement Therapy
14%
IFN Score
14%
Toxic Shock Syndrome toxin-1 (TSST-1)
14%
Streptococcal Toxic Shock Syndrome
14%
P38 Mitogen-activated Protein Kinase Inhibitor
14%
Intensivist
14%
Neutrophil Adhesion
14%
MRNA Expression
14%
Neutrophil Subsets
14%
Kidney Transplant Recipients
14%
Tumor Necrosis Factor-α
14%
Intensive Care
14%
Oxidative Stress Markers
14%
Healthcare Network
14%
Neutrophil Extracellular Traps
14%
Renal Involvement
14%
Immunohistochemical Analysis
14%
Rheumatic Diseases
14%
Serum-free
9%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
9%
Inflammatory Mediators
9%
Adverse Pregnancy Outcomes
9%
Fetal Growth Restriction
9%
Trust Level
9%
CaMKII Inhibitor
8%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin
33%
Rheumatoid Arthritis
30%
Hypoxia Inducible Factor 1
29%
Wegener Granulomatosis
29%
Systemic Sclerosis
29%
Mitogen Activated Protein Kinase P38
24%
Cytokine
21%
Biological Marker
20%
Inflammation
20%
Interstitial Lung Disease
20%
Tumor Necrosis Factor
19%
Mitogen Activated Protein Kinase P38 Inhibitor
18%
Advanced Glycation End Product Receptor
17%
Chemokine
14%
Systemic Lupus Erythematosus
14%
Nephritis
14%
Toxic Shock Syndrome Toxin 1
14%
Liver Cell Carcinoma
14%
Acute Phase Protein
14%
Staphylococcus Aureus
14%
Disease
14%
Pharmacokinetics
14%
Cefotaxime
14%
Pulmonary Hypertension
14%
Interleukin 1beta
11%
Serum Amyloid A
10%
C Reactive Protein
10%
Lupus Erythematosus Nephritis
10%
Superantigen
10%
Disease Activity
7%
Hypoxia
6%
Gelatinase B
6%
Fibrinogen
6%
Protein
5%
